Published on LinkedIn (via Spencer Knight) Pfizer announced plans to acquire Metsera for up to $4.9B, adding GLP-1 and amylin-based...

Published on LinkedIn (via Spencer Knight) Roche announced a $3.5B acquisition of 89bio, adding pegozafermin, a late-stage therapy for...

Published on LinkedIn (via Spencer Knight) LB Pharmaceuticals completed the largest biotech IPO of 2025 to date, raising $285M to advance...

Published on LinkedIn (via Spencer Knight) Novartis has announced its $1.4 billion acquisition of Tourmaline Bio, a New York–based...

Published by Alliance for Regenerative Medicine The cell and gene therapy sector is rapidly expanding, with two blockbuster products...

Published on: See Hua Daily News (诗华日报) Sarawak Central Hospital has successfully performed the state’s first stem cell transplant,...

Published on: LinkedIn (Spencer Knight) The European Commission has approved TEVIMBRA (tislelizumab) from BeOne Medicines, the first PD-1...

Published on: LinkedIn (Spencer Knight) Scientists at Karolinska Institutet have reported a breakthrough gene therapy that restored...

Published on: LinkedIn (Spencer Knight) The FDA has approved Novartis’ Leqvio (inclisiran) as the first siRNA drug to lower LDL-C without...

Published on: ScienceAlert For the first time, a type 1 diabetes patient has begun producing insulin after receiving gene-edited islet...

Published on: LinkedIn (Spencer Knight) In just five days, two breakthrough approvals have reshaped treatment for metabolic...

Published on: LinkedIn (Spencer Knight) The CGT field saw a breakthrough weekend with multiple milestones. Precigen secured FDA approval...

Published on: Autolus Therapeutics The European Commission has granted marketing authorization for AUCATZYL (obecabtagene autoleucel) to...

Published on: Precigen Investors The U.S. FDA has granted full approval to PAPZIMEOS (zopapogene imadenovec-drba), the first therapy for...

Published on: Alliance for Regenerative Medicine The Alliance for Regenerative Medicine’s Q2 2025 Sector Snapshot showcases pivotal...

Published on: Cytotherapy CAR T-cell therapy has transformed outcomes for aggressive B-cell Non-Hodgkin lymphoma, yet many eligible...

Published on: Forbes A clinical trial by Vertex Pharmaceuticals has shown that lab-grown stem cell–derived islet cells can restore...

Published on: Multiple Sclerosis News Today A U.S. trial has treated the first multiple sclerosis (MS) patient with azercabtagene...

Published on: LinkedIn (Spencer Knight) A groundbreaking case in glioblastoma treatment has emerged from a U.S. clinical trial. Pamela...

Published on LinkedIn via Spencer Knight The FDA has given accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) for...